BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Targeting RNA is set to be the next big thing\; 85% of human g
 enome transcribed to RNA but only 3% translated into proteins\, therefore
  making it an obvious target. With Risdiplam being approved by the FDA in
  August\, and several major collaborations also being penned throughout 2
 020\, including a $190 million deal between Arrakis and Roche\, it seems 
 like a good time to target these protein precursors.\n\n&nbsp\;Targeting 
 RNA 2021 will take a look at the latest techniques to analyse and predict
  protein structure\, as well as hearing from leading researchers and indu
 stry on how to incorporate learnings from RNA biology into potent and sel
 ective ligands to help prevent\, rather than treat\, disease.\n\nKey outc
 omes include:&nbsp\;\n\n\nHear how Cryo EM\, 3D visualisation and novel s
 tructural techniques can be used to analyse RNA structure and validate dr
 uggable RNA hotspots in subcellular and high throughput scenarios with se
 ssions from Silvi Rouskin (MIT) and Wah Chiu (Stanford)\nLearn how Pearl 
 Seq and chemical probes can be used to explore the RNA interactome with c
 ase studies from Jay Schneekloth (NIH) and Craig Blain (Arrakis)\nValidat
 e disease relevance and understand what RNA targets are druggable using c
 omputational strategies with talks from Marcel Blommers (Saverna Therapeu
 tics) and Anima Biotech\n
DTEND:20210317T160000
DTSTAMP:20260512T230909Z
DTSTART:20210315T090000
LOCATION:\,
SEQUENCE:0
SUMMARY:Targeting RNA is set to be the next big thing\; 85% of human genom
 e transcribed to RNA but only 3% translated into proteins\, therefore mak
 ing it an...
UID:ba0af4dd-6ec6-4d02-9de3-0d2d0f1da6c7
END:VEVENT
END:VCALENDAR